No takes yet. Share an insight, caveat, or question.
Identifies COH005 as a new PCNA-interacting molecule, implying potential in cancer therapy.
Jossart et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: